Literature DB >> 8106455

The active site substrate specificity of protein kinase C.

Y G Kwon1, M Mendelow, D S Lawrence.   

Abstract

The active site substrate specificity of protein kinase C (PKC) has been evaluated. Like the cAMP-dependent protein kinase (PKA), PKC will efficiently phosphorylate archiral residues attached to an active site-directed peptide. In contrast, PKC exhibits behavior that is dramatically different from PKA with respect to the phosphorylation of alpha-substituted alcohols. Although PKA will only phosphorylate residues that contain the same stereochemistry as that found in L-serine, PKC will phosphorylate alpha-configurational isomers that correspond to both the L- and D-stereoisomers. The possible structural basis for the "dual specificity" of PKC is explored. In an analogous vein, although beta-substituted alcohols that serve as PKA substrates must contain the same stereochemistry as that present in L-threonine, PKC will phosphorylate configurational isomers which correspond to both L-threonine and L-allo-threonine. The implications of these observations with respect to protein kinase inhibitor design are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106455

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Selection and optimization of enzyme reporters for chemical cytometry.

Authors:  Angela Proctor; Qunzhao Wang; David S Lawrence; Nancy L Allbritton
Journal:  Methods Enzymol       Date:  2019-03-23       Impact factor: 1.600

2.  The specificity of the protein kinase C alpha, betaII and gamma isoforms as assessed by an unnatural alcohol-appended peptide library.

Authors:  X Yan; K Curley; D S Lawrence
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

3.  The design of peptide-based substrates for the cdc2 protein kinase.

Authors:  J Srinivasan; M Koszelak; M Mendelow; Y G Kwon; D S Lawrence
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.